AHSG and hepatocellular carcinoma: Since liver cells make most of the Ahsg in the blood stream, it was interesting to observe that liver cancer cells (hepatocellular carcinoma) that produce the high levels of Ahsg (RNAseq) have a better overall survival compared to those that produce low levels of Ahsg, with a median survival of 71.03 months for high expression vs. 73 months for low expression [57,58].